625 related articles for article (PubMed ID: 3928676)
21. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
22. Hormonal regulation of male reproduction (with reference to infertility in man).
Courot M
Andrologia; 1976; 8(3):187-93. PubMed ID: 999040
[TBL] [Abstract][Full Text] [Related]
23. Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism.
Lin J; Mao J; Wang X; Ma W; Hao M; Wu X
Medicine (Baltimore); 2019 Aug; 98(31):e16616. PubMed ID: 31374027
[TBL] [Abstract][Full Text] [Related]
24. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience.
Yang L; Zhang SX; Dong Q; Xiong ZB; Li X
Int Urol Nephrol; 2012 Apr; 44(2):393-9. PubMed ID: 21989858
[TBL] [Abstract][Full Text] [Related]
25. [The application of gonadotropin in treatment of male central hypogonadism].
Di FS; Cui YG; Jia Y
Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):836-9. PubMed ID: 16316564
[TBL] [Abstract][Full Text] [Related]
26. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
[TBL] [Abstract][Full Text] [Related]
27. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
[TBL] [Abstract][Full Text] [Related]
28. Gonadotropin treatment of hypogonadotropic hypogonadal adolescents.
Bouvattier C; Tauber M; Jouret B; Chaussain JL; Rochiccioli P
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():339-44. PubMed ID: 10698599
[TBL] [Abstract][Full Text] [Related]
29. Hypogonadotropic hypogonadism: gonadotropin therapy.
Snyder PJ
Curr Ther Endocrinol Metab; 1994; 5():300-3. PubMed ID: 7704739
[No Abstract] [Full Text] [Related]
30. Pulsatile gonadotropin-releasing hormone treatment of men with idiopathic hypogonadotropic hypogonadism.
Christiansen P; Skakkebaek NE
Horm Res; 2002; 57(1-2):32-6. PubMed ID: 12006717
[TBL] [Abstract][Full Text] [Related]
31. Daytime plasma melatonin levels in male hypogonadism.
Ozata M; Bulur M; Bingol N; Beyhan Z; Corakci A; Bolu E; Gundogan MA
J Clin Endocrinol Metab; 1996 May; 81(5):1877-81. PubMed ID: 8626851
[TBL] [Abstract][Full Text] [Related]
32. hCG-induced maturation of the seminiferous epithelium in hypogonadotropic men.
D'Agata R; Heindel JJ; Vicari E; Aliffi A; Gulizia S; Polosa P
Horm Res; 1984; 19(1):23-32. PubMed ID: 6420302
[TBL] [Abstract][Full Text] [Related]
33. Improvement of spermatogenesis by hCG and hMG treatment in pubertal boys with history of orchiopexy at early childhood.
Okuyama A; Namiki M; Aono T; Matsumoto K; Utsunomiya M; Itoh H; Yoshioka T; Itatani H; Sonoda T
Arch Androl; 1984; 12 Suppl():29-33. PubMed ID: 6152576
[TBL] [Abstract][Full Text] [Related]
34. Hormonal control of spermatogenesis in men: therapeutic aspects in hypogonadotropic hypogonadism.
Pitteloud N; Dwyer A
Ann Endocrinol (Paris); 2014 May; 75(2):98-100. PubMed ID: 24793994
[TBL] [Abstract][Full Text] [Related]
35. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone.
Bouloux PM; Nieschlag E; Burger HG; Skakkebaek NE; Wu FC; Handelsman DJ; Baker GH; Ochsenkuehn R; Syska A; McLachlan RI; Giwercman A; Conway AJ; Turner L; van Kuijk JH; Voortman G
J Androl; 2003; 24(4):604-11. PubMed ID: 12826700
[TBL] [Abstract][Full Text] [Related]
36. Restoration of fertility by gonadotropin replacement in a man with hypogonadotropic azoospermia and testicular adrenal rest tumors due to untreated simple virilizing congenital adrenal hyperplasia.
Rohayem J; Tüttelmann F; Mallidis C; Nieschlag E; Kliesch S; Zitzmann M
Eur J Endocrinol; 2014 Apr; 170(4):K11-7. PubMed ID: 24394723
[TBL] [Abstract][Full Text] [Related]
37. Gonadotropin Treatment for the Male Hypogonadotropic Hypogonadism.
Boeri L; Capogrosso P; Salonia A
Curr Pharm Des; 2021; 27(24):2775-2783. PubMed ID: 32445446
[TBL] [Abstract][Full Text] [Related]
38. Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study.
Chen YW; Niu YH; Xu H; Wang DQ; Jiang HY; Pokhrel G; Wang T; Wang SG; Liu JH
Asian J Androl; 2019; 21(4):413-418. PubMed ID: 30604694
[TBL] [Abstract][Full Text] [Related]
39. Hormonal therapy of male hypogonadism.
Matsumoto AM
Endocrinol Metab Clin North Am; 1994 Dec; 23(4):857-75. PubMed ID: 7705324
[TBL] [Abstract][Full Text] [Related]
40. [A hormone assay as a therapeutic choice in male sterility].
Avril-Ducarne C; Kuhn JM; Cossec A; Bastit P; Bisson JP; Wolf LM
J Gynecol Obstet Biol Reprod (Paris); 1990; 19(7):881-8. PubMed ID: 2126018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
